drugset / Trial / NCT01670357
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is to determine the efficacy and safety of 3% or 5% DA-6034 eye drops compared with placebo in dry eye syndrome.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RECOFLAVONE | Small molecule | 3 % | Other |
| Subject | RECOFLAVONE | Small molecule | 5 % | Other |